Jun 22, 2020
Aethlon Medical Presents Hemopurifier® Data at the American Association for Cancer Research 2020 Annual Meeting
May 27, 2020
Evox Therapeutics Appoints Martin Andrews as Non-Executive Director
May 26, 2020
FDA Authorized Emergency Compassionate Use Investigational New Drug Applications for Treatment of COVID-19 at Landmark Hospitals
May 19, 2020
Evox Therapeutics Appoints Dr Sonya Montgomery as Chief Medical Officer
May 14, 2020
Evox Therapeutics Appoints Paul Carter as Non-executive Chairman
Apr 06, 2020
ReNeuron Update Regarding COVID-19
Mar 30, 2020
Extracellular Vesicles From Plasma Have Higher Tumor RNA Fraction Than Platelets
Mar 26, 2020
Evox Therapeutics and Takeda Sign Multi-target Rare Disease Collaboration
Mar 24, 2020
Aethlon Announces Issuance of European Patent for the Hemopurifier® in Cancer
Mar 04, 2020
Newfound Cell Defense System Features Toxin-Isolating "Sponges"
Feb 27, 2020
NanoView Biosciences and Izasa Scientific Enter into Distribution Agreement
Feb 06, 2020
Aethlon Medical To Release Third Quarter Financial Results and Host Conference Call on February 10, 2020
Jan 15, 2020
Study Shows More Effective, Safer Way to Develop Stem Cells for Treating Brain Damage
Jan 07, 2020
Aegle Therapeutics Announces $4M Financing to Fund Groundbreaking Stem Cell Exosome Clinical Trial to Treat Orphan Disease Dystrophic Epidermolysis Bullosa
Jan 06, 2020
R3 Stem Cell Training Course Adds Renowned Exosome Therapy Speaker for January 2020 Course
Nov 06, 2019
Regen Suppliers Now Offering Amniotic Derived Exosome Product, NeoCyteXO
Oct 22, 2019
Kimera Labs announces Exosome Education Seminars at its 27,000 sq ft state-of-the-art biochemical laboratory and production campus
Oct 10, 2019
R3 Stem Cell Announces Addition of World Renowned Exosome Expert Dr. Ian White to Training Course
Oct 07, 2019
Aethlon Medical Announces FDA Approval Of IDE For Oncology Indications
Sep 24, 2019
Aethlon Announces Collaboration to Identify Exosomes Involved in Cancer Progression and Treatment Resistance